Figure 12. Regulatory molecular prediction of K-CRGs. (A) The ceRNA network of K-CRGs. (B) The targeted drug network of K-CRGs. (C) Forecast of combinative location between FDX1 and latamoxef (their combined free energy is -7.7). (D) Forecast of combinative location between FDX1 and glibenclamide (their combined free energy is -7.5). (E) Forecast of combinative location between MAP2K1 and dasatinib (their combined free energy is -9.8). (F) Forecast of combinative location between MAP2K1 and sorafenib (their combined free energy is -9.7). (G) Forecast of combinative location between SLC31A1 and lycorine (their combined free energy is -5.5). (H) Forecast of combinative location between SLC31A1 and parthenolide (their combined free energy is -5.1).